IL15 and breast cancer: Specifically, NK-EVs primed with IL-15 have demonstrated remarkable cytotoxic activity against various human cancers such as glioblastoma and breast cancer through increasing the expression of apoptotic molecules (e.g., perforin, granzyme B, FasL, and caspases) [30].